Institutional investors purchased a net $1.5 million shares of DEPO during the quarter ended December 2016 and now own 98.49% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STARBOARD VALUE LP Bought 25.0 Thousand shares of Depomed Inc
BMO ASSET MANAGEMENT, INC. Bought 4.0 Thousand shares of Depomed Inc
CREDIT SUISSE AG Bought 3.3 Thousand shares of Depomed Inc